<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>28(1)</volume><submitter>Latosinska JN</submitter><pubmed_abstract>A series of new congeners, 1-[2-(1-adamantyl)ethyl]-1&lt;i>H&lt;/i>-benzimidazole (AB) and 1-[2-(1-adamantyl)ethyl]-4,5,6,7-tetrahalogeno-1&lt;i>H&lt;/i>-benzimidazole (Hal=Cl, Br, I; tClAB, tBrAB, tIAB), have been synthesized and studied. These novel multi-target ligands combine a benzimidazole ring known to show antitumor activity and an adamantyl moiety showing anti-influenza activity. Their crystal structures were determined by X-ray, while intermolecular interactions were studied using topological Bader's Quantum Theory of Atoms in Molecules, Hirshfeld Surfaces, CLP and PIXEL approaches. The newly synthesized compounds crystallize within two different space groups, P-1 (AB and tIAB) and P2&lt;sub>1&lt;/sub>/c (tClAB and tBrAB). A number of intramolecular hydrogen bonds, C-H⋯Hal (Hal=Cl, Br, I), were fo</pubmed_abstract><journal>Molecules (Basel, Switzerland)</journal><pagination>147</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9822452</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Synthesis and Crystal Structure of Adamantylated 4,5,6,7-Tetrahalogeno-1&lt;i>H&lt;/i>-benzimidazoles Novel Multi-Target Ligands (Potential CK2, M2 and SARS-CoV-2 Inhibitors); X-ray/DFT/QTAIM/Hirshfeld Surfaces/Molecular Docking Study.</pubmed_title><pmcid>PMC9822452</pmcid><pubmed_authors>Latosinska JN</pubmed_authors><pubmed_authors>Orzeszko A</pubmed_authors><pubmed_authors>Latosinska M</pubmed_authors><pubmed_authors>Maurin JK</pubmed_authors></additional><is_claimable>false</is_claimable><name>Synthesis and Crystal Structure of Adamantylated 4,5,6,7-Tetrahalogeno-1&lt;i>H&lt;/i>-benzimidazoles Novel Multi-Target Ligands (Potential CK2, M2 and SARS-CoV-2 Inhibitors); X-ray/DFT/QTAIM/Hirshfeld Surfaces/Molecular Docking Study.</name><description>A series of new congeners, 1-[2-(1-adamantyl)ethyl]-1&lt;i>H&lt;/i>-benzimidazole (AB) and 1-[2-(1-adamantyl)ethyl]-4,5,6,7-tetrahalogeno-1&lt;i>H&lt;/i>-benzimidazole (Hal=Cl, Br, I; tClAB, tBrAB, tIAB), have been synthesized and studied. These novel multi-target ligands combine a benzimidazole ring known to show antitumor activity and an adamantyl moiety showing anti-influenza activity. Their crystal structures were determined by X-ray, while intermolecular interactions were studied using topological Bader's Quantum Theory of Atoms in Molecules, Hirshfeld Surfaces, CLP and PIXEL approaches. The newly synthesized compounds crystallize within two different space groups, P-1 (AB and tIAB) and P2&lt;sub>1&lt;/sub>/c (tClAB and tBrAB). A number of intramolecular hydrogen bonds, C-H⋯Hal (Hal=Cl, Br, I), were fo</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Dec</publication><modification>2026-04-08T10:50:49.649Z</modification><creation>2024-12-03T15:48:16.48Z</creation></dates><accession>S-EPMC9822452</accession><cross_references><pubmed>36615341</pubmed><doi>10.3390/molecules28010147</doi></cross_references></HashMap>